MWA
BIIB icon

Medallion Wealth Advisors’s Biogen BIIB Stock Holding History

Medallion Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46K Sell
16
-57
-78% -$10.9K ﹤0.01% 910
2026
Q1 		$13.4K Hold
73
– – ﹤0.01% 724
2025
Q4 		$12.8K Hold
73
– – ﹤0.01% 717
2025
Q3 		$10.2K Sell
73
-42
-37% -$5.68K ﹤0.01% 742
2025
Q2 		$14.4K Hold
115
– – 0.01% 686
2025
Q1 		$15.7K Hold
115
– – 0.01% 616
2024
Q4 		$15.7K Buy
+115
New +$19.4K 0.01% 599

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Medallion Wealth Advisors's BIIB Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its Biogen (BIIB) stake by 78% in Q2 2026, selling an estimated $10.9K and leaving 16 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Medallion Wealth Advisors first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.7K in Q1 2025. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Medallion Wealth Advisors held 16 shares of Biogen worth $3.46K as of Q2 2026.
  • Medallion Wealth Advisors sold 57 Biogen shares in Q2 2026, an estimated $10.9K.
  • Biogen made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #910 holding.
  • Medallion Wealth Advisors first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Biogen position peaked at $15.7K in Q1 2025.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.